Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $CTOR
Citius Oncology Inc.
Subscribe to $CTOR
$CTOR
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2022
Exchange: NASDAQ
Recent Analyst Ratings for Citius Oncology Inc.
Date
Price Target
Rating
Analyst
11/27/2024
$3.00
Buy
Maxim Group
See more ratings
